Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMG Biofeedback and Pharmacotherapy in Bruxism
NCT06894472Not yet recruiting
- Sponsor
- Beni Suef University
- Start
- Mar 2025
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Beni Suef University. Primary endpoint: Assessment of Masseter Hyperactivity at 4 weeks. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06894472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06894472.